iRobot  vs Rockwell Automation: The Best RPA Stock to Look for in 2022

iRobot  vs Rockwell Automation: The Best RPA Stock to Look for in 2022
Published on

Pick the best RPA stock with the best value, the fastest growth, and the most momentum

The number of robotics process automation companies has increased dramatically in recent decades as corporations seek to produce goods and services more efficiently, often replacing more expensive human employees in the process. In recent years, the urgency to automate to cut labor costs has accelerated due to intensifying global competition and other forces.  In 2016, the global RPA spending was US$300 million. That number is expected to reach US$7.2 billion by the end of the year in 2022 and skyrocket to US$10.4 billion by 2023. Here are the top two RPA stocks – iRobot and Rockwell Automation, with the best value, the fastest growth, and the most momentum. Pick a better RPA stock for your investment.

iRobot is a global consumer robot company. It designs and builds robots for use inside and outside the home. One of its main products is the Roomba, a robot designed to automatically vacuum floors. On Nov. 18, 2021, iRobot announced that it had acquired Aeris Cleantec A.G., a privately held air purifier company based in Switzerland. The financial terms of the transaction were not disclosed. iRobot plans to integrate Aeris' products with its existing product lineup of home robots. The global residential air purifier market is expected to expand from US$3.4 billion in 2020 to more than US$6.7 billion in 2027. Its current RPA stock is US$45.04, 0.55% down from the previous close.

Rockwell Automation provides industrial automation and digital transformation solutions. The company offers intelligent devices for motion, safety, and sense, as well as control and visualization software and hardware, network and security infrastructure, and similar products. In December 2021, Rockwell announced that it had partnered with global life sciences company Cytiva to collaborate on several projects to accelerate the development and delivery of medicines and lower costs. Its current RPA stock is US$214.87, 1.11% down from the previous close.

Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp

                                                                                                       _____________                                             

Disclaimer: Analytics Insight does not provide financial advice or guidance. Also note that the cryptocurrencies mentioned/listed on the website could potentially be scams, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. You are responsible for conducting your own research (DYOR) before making any investments. Read more here.

Related Stories

No stories found.
logo
Analytics Insight
www.analyticsinsight.net